http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 14 May 2024 08:25:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Acorda+Therapeutics%2C++++++For%3A+Mar+31/23220255.html si-local-file:///var/storage/secattach/20240514/23220255.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Acorda+Therapeutics%2C++++++For%3A+Mar+31/23220255.html Tue, 14 May 2024 08:25:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Acorda+Therapeutics%2C++++++For%3A+Mar+31/23220255.html si-local-file:///var/storage/secattach/20240514/23220255.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Acorda+Therapeutics%2C++++++For%3A+Mar+31/23220255.html Tue, 14 May 2024 08:25:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Acorda+Therapeutics%2C++++++For%3A+Dec+31/23133086.html si-local-file:///var/storage/secattach/20240429/23133086.html http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Acorda+Therapeutics%2C++++++For%3A+Dec+31/23133086.html Mon, 29 Apr 2024 08:39:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Acorda+Therapeutics%2C++++++For%3A+Dec+31/23133086.html si-local-file:///var/storage/secattach/20240429/23133086.html http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Acorda+Therapeutics%2C++++++For%3A+Dec+31/23133086.html Mon, 29 Apr 2024 08:39:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+25/23123298.html si-local-file:///var/storage/secattach/20240426/23123298.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+25/23123298.html Fri, 26 Apr 2024 06:09:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+25/23123298.html si-local-file:///var/storage/secattach/20240426/23123298.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+25/23123298.html Fri, 26 Apr 2024 06:09:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Acorda+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23115602.html si-local-file:///var/storage/secattach/20240425/23115602.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Acorda+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23115602.html Thu, 25 Apr 2024 09:11:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Acorda+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23115602.html si-local-file:///var/storage/secattach/20240425/23115602.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Acorda+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23115602.html Thu, 25 Apr 2024 09:11:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+12/23077605.html si-local-file:///var/storage/secattach/20240417/23077605.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+12/23077605.html Wed, 17 Apr 2024 09:11:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+12/23077605.html si-local-file:///var/storage/secattach/20240417/23077605.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+12/23077605.html Wed, 17 Apr 2024 09:11:00 -0400 ACOR O.00186577 http://www.streetinsider.com/Corporate+News/Acorda+Therapeutics+%28ACOR%29+Announces+Delisting/23068468.html <p>Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market platform operated by OTC Markets Group Inc. http://www.streetinsider.com/Corporate+News/Acorda+Therapeutics+%28ACOR%29+Announces+Delisting/23068468.html Mon, 15 Apr 2024 17:06:59 -0400 ACOR ACORQ http://www.streetinsider.com/Corporate+News/Acorda+Therapeutics+%28ACOR%29+Announces+Delisting/23068468.html <p>Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market platform operated by OTC Markets Group Inc. http://www.streetinsider.com/Corporate+News/Acorda+Therapeutics+%28ACOR%29+Announces+Delisting/23068468.html Mon, 15 Apr 2024 17:06:59 -0400 ACOR ACORQ http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html Mon, 15 Apr 2024 17:03:00 -0400 ACOR ACORQ O.00186577 http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html Mon, 15 Apr 2024 17:03:00 -0400 ACOR ACORQ O.00186577 http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html Mon, 15 Apr 2024 17:03:00 -0400 ACOR ACORQ O.00186577 http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html Mon, 15 Apr 2024 17:03:00 -0400 ACOR ACORQ O.00186577 http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html Mon, 15 Apr 2024 17:03:00 -0400 ACOR ACORQ O.00186577 http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink<span>®</span> Open Market http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Delisting+from+Nasdaq/23068432.html Mon, 15 Apr 2024 17:03:00 -0400 ACOR ACORQ O.00186577 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+03/23026271.html si-local-file:///var/storage/secattach/20240404/23026271.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+03/23026271.html Thu, 04 Apr 2024 06:01:00 -0400 ACOR O.00186577 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+03/23026271.html si-local-file:///var/storage/secattach/20240404/23026271.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Acorda+Therapeutics%2C++++++For%3A+Apr+03/23026271.html Thu, 04 Apr 2024 06:01:00 -0400 ACOR O.00186577 http://www.streetinsider.com/Corporate+News/Acorda+Therapeutics+%28ACOR%29+Receives+Nasdaq+Delisting+Notice/23024632.html <p>Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announcement that it has reached an agreement with Merz Therapeutics to acquire substantially all of the assets of the Company. In connection with that announcement, Acorda and certain of its affiliates filed voluntary petitions to commence Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York. Nasdaq commenced proceedings to http://www.streetinsider.com/Corporate+News/Acorda+Therapeutics+%28ACOR%29+Receives+Nasdaq+Delisting+Notice/23024632.html Wed, 03 Apr 2024 17:30:50 -0400 ACOR http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announcement that it has reached an agreement with Merz Therapeutics to acquire substantially all of the assets of the Company. In connection with that announcement, Acorda and certain of its affiliates filed voluntary petitions to commence Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html Wed, 03 Apr 2024 17:30:00 -0400 ACOR O.00186577 http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announcement that it has reached an agreement with Merz Therapeutics to acquire substantially all of the assets of the Company. In connection with that announcement, Acorda and certain of its affiliates filed voluntary petitions to commence Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District http://www.streetinsider.com/Press+Releases/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html Wed, 03 Apr 2024 17:30:00 -0400 ACOR O.00186577 http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announcement that it has reached an agreement with Merz Therapeutics to acquire substantially all of the assets of the Company. In connection with that announcement, Acorda and certain of its affiliates filed voluntary petitions to commence Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html Wed, 03 Apr 2024 17:30:00 -0400 ACOR O.00186577 http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html <p> PEARL RIVER, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announcement that it has reached an agreement with Merz Therapeutics to acquire substantially all of the assets of the Company. In connection with that announcement, Acorda and certain of its affiliates filed voluntary petitions to commence Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District http://www.streetinsider.com/Business+Wire/Acorda+Therapeutics+Announces+Nasdaq+Delisting+Notification/23024615.html Wed, 03 Apr 2024 17:30:00 -0400 ACOR O.00186577